SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001626199-23-000106
Filing Date
2023-11-06
Accepted
2023-11-06 06:02:35
Documents
12
Period of Report
2023-11-06
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K alpn-20231106.htm   iXBRL 8-K 31869
  Complete submission text file 0001626199-23-000106.txt   162108

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alpn-20231106.xsd EX-101.SCH 1953
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alpn-20231106_lab.xml EX-101.LAB 24851
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alpn-20231106_pre.xml EX-101.PRE 13084
6 EXTRACTED XBRL INSTANCE DOCUMENT alpn-20231106_htm.xml XML 2827
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37449 | Film No.: 231377971
SIC: 2834 Pharmaceutical Preparations